Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Previous studies with hypertriglyceridemic APOC3 transgenic mice have suggested that apolipoprotein C-III (apoC-III) may inhibit either the apoE-mediated hepatic uptake of TG-rich lipoproteins and/or the lipoprotein lipase (LPL)-mediated hydrolysis of TG. Accordingly, apoC3 knockout (apoC3−/−) mice...

Full description

Bibliographic Details
Main Authors: Miek C. Jong, Patrick C.N. Rensen, Vivian E.H. Dahlmans, Hans van der Boom, Theo J.C. van Berkel, Louis M. Havekes
Format: Article
Language:English
Published: Elsevier 2001-10-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520322112
id doaj-b7db1849ec62483f8e3fa15276782742
record_format Article
spelling doaj-b7db1849ec62483f8e3fa152767827422021-04-27T04:42:15ZengElsevierJournal of Lipid Research0022-22752001-10-01421015781585Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout miceMiek C. Jong0Patrick C.N. Rensen1Vivian E.H. Dahlmans2Hans van der Boom3Theo J.C. van Berkel4Louis M. Havekes5TNO-Prevention and Health, Gaubius Laboratory, 2301 CE Leiden, The NetherlandsDivision of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, Sylvius Laboratory, 2300 RA Leiden, The NetherlandsTNO-Prevention and Health, Gaubius Laboratory, 2301 CE Leiden, The NetherlandsTNO-Prevention and Health, Gaubius Laboratory, 2301 CE Leiden, The NetherlandsDivision of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, University of Leiden, Sylvius Laboratory, 2300 RA Leiden, The NetherlandsTNO-Prevention and Health, Gaubius Laboratory, 2301 CE Leiden, The Netherlands; Departments of Cardiology and Internal Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands; TNO-Prevention and Health, Gaubius Laboratory Zernikedreef 9, P.O. Box 2215 Leiden 2301 CE, The NetherlandsPrevious studies with hypertriglyceridemic APOC3 transgenic mice have suggested that apolipoprotein C-III (apoC-III) may inhibit either the apoE-mediated hepatic uptake of TG-rich lipoproteins and/or the lipoprotein lipase (LPL)-mediated hydrolysis of TG. Accordingly, apoC3 knockout (apoC3−/−) mice are hypotriglyceridemic. In the present study, we attempted to elucidate the mechanism(s) underlying these phenomena by intercrossing apoC3−/− mice with apoE−/− mice to study the effects of apoC-III deficiency against a hyperlipidemic background. Similar to apoE+/+ apoC3−/− mice, apoE−/−apoC3−/− mice exhibited a marked reduction in VLDL cholesterol and TG, indicating that the mechanism(s) by which apoC-III deficiency exerts its lipid-lowering effect act independent of apoE. On both backgrounds, apoC3−/− mice showed normal intestinal lipid absorption and hepatic VLDL TG secretion. However, turnover studies showed that TG-labeled emulsion particles were cleared much more rapidly in apoC3−/− mice, whereas the clearance of VLDL apoB, as a marker for whole particle uptake by the liver, was not affected. Furthermore, it was shown that cholesteryl oleate-labeled particles were also cleared faster in apoC3−/− mice. Thus the mechanisms underlying the hypolipidemia in apoC3−/− mice involve both a more efficient hydrolysis of VLDL TG as well as an enhanced selective clearance of VLDL cholesteryl esters from plasma.In summary, our studies of apoC3−/− mice support the concept that apoC-III is an effective inhibitor of VLDL TG hydrolysis and reveal a potential regulating role for apoC-III with respect to the selective uptake of cholesteryl esters.http://www.sciencedirect.com/science/article/pii/S0022227520322112hypercholesterolemiatransgenic micetriglyceride metabolism
collection DOAJ
language English
format Article
sources DOAJ
author Miek C. Jong
Patrick C.N. Rensen
Vivian E.H. Dahlmans
Hans van der Boom
Theo J.C. van Berkel
Louis M. Havekes
spellingShingle Miek C. Jong
Patrick C.N. Rensen
Vivian E.H. Dahlmans
Hans van der Boom
Theo J.C. van Berkel
Louis M. Havekes
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
Journal of Lipid Research
hypercholesterolemia
transgenic mice
triglyceride metabolism
author_facet Miek C. Jong
Patrick C.N. Rensen
Vivian E.H. Dahlmans
Hans van der Boom
Theo J.C. van Berkel
Louis M. Havekes
author_sort Miek C. Jong
title Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
title_short Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
title_full Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
title_fullStr Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
title_full_unstemmed Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
title_sort apolipoprotein c-iii deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoe knockout mice
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2001-10-01
description Previous studies with hypertriglyceridemic APOC3 transgenic mice have suggested that apolipoprotein C-III (apoC-III) may inhibit either the apoE-mediated hepatic uptake of TG-rich lipoproteins and/or the lipoprotein lipase (LPL)-mediated hydrolysis of TG. Accordingly, apoC3 knockout (apoC3−/−) mice are hypotriglyceridemic. In the present study, we attempted to elucidate the mechanism(s) underlying these phenomena by intercrossing apoC3−/− mice with apoE−/− mice to study the effects of apoC-III deficiency against a hyperlipidemic background. Similar to apoE+/+ apoC3−/− mice, apoE−/−apoC3−/− mice exhibited a marked reduction in VLDL cholesterol and TG, indicating that the mechanism(s) by which apoC-III deficiency exerts its lipid-lowering effect act independent of apoE. On both backgrounds, apoC3−/− mice showed normal intestinal lipid absorption and hepatic VLDL TG secretion. However, turnover studies showed that TG-labeled emulsion particles were cleared much more rapidly in apoC3−/− mice, whereas the clearance of VLDL apoB, as a marker for whole particle uptake by the liver, was not affected. Furthermore, it was shown that cholesteryl oleate-labeled particles were also cleared faster in apoC3−/− mice. Thus the mechanisms underlying the hypolipidemia in apoC3−/− mice involve both a more efficient hydrolysis of VLDL TG as well as an enhanced selective clearance of VLDL cholesteryl esters from plasma.In summary, our studies of apoC3−/− mice support the concept that apoC-III is an effective inhibitor of VLDL TG hydrolysis and reveal a potential regulating role for apoC-III with respect to the selective uptake of cholesteryl esters.
topic hypercholesterolemia
transgenic mice
triglyceride metabolism
url http://www.sciencedirect.com/science/article/pii/S0022227520322112
work_keys_str_mv AT miekcjong apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
AT patrickcnrensen apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
AT vivianehdahlmans apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
AT hansvanderboom apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
AT theojcvanberkel apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
AT louismhavekes apolipoproteinciiideficiencyacceleratestriglyceridehydrolysisbylipoproteinlipaseinwildtypeandapoeknockoutmice
_version_ 1721506831403057152